Cancer
Beyond HPV: oncomirs as new players in cervical cancer.
Reshmi G, Pillai MR.
FEBS Lett. 2008 Dec 24;582(30):4113-6.
miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels.
Abdelmohsen K, Srikantan S, Kuwano Y, Gorospe M.
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20297-302.
Role of silencing phosphatase of regenerationg liver-3 expression by microRNA interference in the growth of gastric cancer.
Cai SR, Wang Z, Chen CQ, Wu WH, He YL, Zhan WH, Zhang CH, Cui J, Wu H.
Chin Med J (Engl). 2008 Dec 20;121(24):2534-8.
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G.
Chen Y, Liu W, Chao T, Zhang Y, Yan X, Gong Y, Qiang B, Yuan J, Sun M, Peng X.
Cancer Lett. 2008 Dec 18;272(2):197-205.
Dicer, Drosha, and outcomes in patients with ovarian cancer.
Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, Deavers MT,
Mourad-Zeidan A, Wang H, Mueller P, Lenburg ME, Gray JW, Mok S, Birrer MJ, Lopez-Berestein G, Coleman RL, Bar-Eli M, Sood AK.
N Engl J Med. 2008 Dec 18;359(25):2641-50.
MicroRNA in cancer prognosis.
Slack FJ, Weidhaas JB.
N Engl J Med. 2008 Dec 18;359(25):2720-2.
MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc.
Aguda BD, Kim Y, Piper-Hunter MG, Friedman A, Marsh CB.
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19678-83.
Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway.
Zenz T, Benner A, Döhner H, Stilgenbauer S.
Cell Cycle. 2008 Dec 15;7(24):3810-4.
MicroRNA alterations in head and neck squamous cell carcinoma.
Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, Glazer C, Shan S, Westra W, Sidransky D, Califano JA.
Int J Cancer. 2008 Dec 15;123(12):2791-7.
p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.
Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, Ørntoft TF, Andersen CL, Dobbelstein M.
Cancer Res. 2008 Dec 15;68(24):10094-104.
Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
Georges SA, Biery MC, Kim SY, Schelter JM, Guo J, Chang AN, Jackson AL, Carleton MO, Linsley PS, Cleary MA, Chau BN.
Cancer Res. 2008 Dec 15;68(24):10105-12.
MicroRNAs impair MET-mediated invasive growth.
Migliore C, Petrelli A, Ghiso E, Corso S, Capparuccia L, Eramo A, Comoglio PM, Giordano S.
Cancer Res. 2008 Dec 15;68(24):10128-36.
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.
Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, Liang S, Leminen A, Deng S, Smith L, Johnstone CN, Chen XM, Liu CG,
Huang Q, Katsaros D, Calin GA, Weber BL, Bützow R, Croce CM, Coukos G, Zhang L.
Cancer Res. 2008 Dec 15;68(24):10307-14.
miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit.
Song B, Wang Y, Kudo K, Gavin EJ, Xi Y, Ju J.
Clin Cancer Res. 2008 Dec 15;14(24):8080-6.
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.
Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, Brenner JC, Yu J, Kim JH,
Han B, Tan P, Kumar-Sinha C, Lonigro RJ, Palanisamy N, Maher CA, Chinnaiyan AM.
Science. 2008 Dec 12;322(5908):1695-9.
Altered microRNA expression patterns in irradiated hematopoietic tissues suggest a sex-specific protective mechanism.
Ilnytskyy Y, Zemp FJ, Koturbash I, Kovalchuk O.
Biochem Biophys Res Commun. 2008 Dec 5;377(1):41-5.
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T, Ito M.
Biochem Biophys Res Commun. 2008 Dec 5;377(1):114-9.
The cell growth suppressor, mir-126, targets IRS-1.
Zhang J, Du YY, Lin YF, Chen YT, Yang L, Wang HJ, Ma D.
Biochem Biophys Res Commun. 2008 Dec 5;377(1):136-40.
Geographical mapping of a multifocal thyroid tumour using genetic alteration analysis & miRNA profiling.
Aherne ST, Smyth PC, Flavin RJ, Russell SM, Denning KM, Li JH, Guenther SM, O'Leary JJ, Sheils OM.
Mol Cancer. 2008 Dec 4;7:89.
MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival.
Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M.
J Gastrointest Surg. 2008 Dec;12(12):2171-6.
MicroRNA involvement in hepatocellular carcinoma.
Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G, Croce CM, Bolondi L, Negrini M.
J Cell Mol Med. 2008 Dec;12(6A):2189-204.
[Oncogenic and tumour suppressor microRNAs]
Finoux AL, Chartrand P.
Med Sci (Paris). 2008 Dec;24(12):1049-54.
Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma.
Skawran B, Steinemann D, Becker T, Buurman R, Flik J, Wiese B, Flemming P, Kreipe H, Schlegelberger B, Wilkens L.
Mod Pathol. 2008 Dec;21(12):1479-89.
Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3.
Zhang S, Cai X, Huang F, Zhong W, Yu Z.
Exp Oncol. 2008 Dec;30(4):265-8.
Role of miRNA-146a in the regulation of the innate immune response and cancer.
Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA.
Biochem Soc Trans. 2008 Dec;36(Pt 6):1211-5.
Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
Agirre X, Jiménez-Velasco A, San José-Enériz E, Garate L, Bandrés E, Cordeu L, Aparicio O, Saez B, Navarro G, Vilas-Zornoza A,
Pérez-Roger I, García-Foncillas J, Torres A, Heiniger A, Calasanz MJ, Fortes P, Román-Gómez J, Prósper F.
Mol Cancer Res. 2008 Dec;6(12):1830-40.
MicroRNAs and cancer: past, present, and potential future.
Nelson KM, Weiss GJ.
Mol Cancer Ther. 2008 Dec;7(12):3655-60.
Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco
carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Kalscheuer S, Zhang X, Zeng Y, Upadhyaya P.
Carcinogenesis. 2008 Dec;29(12):2394-9.
DNA damage-induced upregulation of miR-709 in the germline downregulates BORIS to counteract aberrant DNA hypomethylation.
Tamminga J, Kathiria P, Koturbash I, Kovalchuk O.
Cell Cycle. 2008 Dec;7(23):3731-6.
Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sun BS, Dong QZ, Ye QH, Sun HJ, Jia HL, Zhu XQ, Liu DY, Chen J, Xue Q, Zhou HJ, Ren N, Qin LX.
Hepatology. 2008 Dec;48(6):1834-42.
MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.
Iorio MV, Casalini P, Tagliabue E, Ménard S, Croce CM.
Eur J Cancer. 2008 Dec;44(18):2753-9.
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
Leucci E, Cocco M, Onnis A, De Falco G, van Cleef P, Bellan C, van Rijk A, Nyagol J, Byakika B, Lazzi S, Tosi P, van Krieken H, Leoncini
L.
J Pathol. 2008 Dec;216(4):440-50.
Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M,
Moriyama M.
J Pathol. 2008 Dec;216(4):418-27.
miR-21 plays a pivotal role in gastric cancer pathogenesis and progression.
Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W, Xiao S, Lu H.
Lab Invest. 2008 Dec;88(12):1358-66.
Role of microRNAs in drug-resistant ovarian cancer cells.
Sorrentino A, Liu CG, Addario A, Peschle C, Scambia G, Ferlini C.
Gynecol Oncol. 2008 Dec;111(3):478-86.
Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to
doxorubicin-induced apoptosis by miR-1.
Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, Wang B, Suster S, Jacob ST, Ghoshal K.
J Biol Chem. 2008 Nov 28;283(48):33394-405.
MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
Luthra R, Singh RR, Luthra MG, Li YX, Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, Broaddus RR, Rashid A,
Albarracin CT.
Oncogene. 2008 Nov 27;27(52):6667-78.
Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
Müller DW, Bosserhoff AK.
Oncogene. 2008 Nov 27;27(52):6698-706.
Genetic analysis of cancer-implicated MicroRNA in ovarian cancer.
Bearfoot JL, Choong DY, Gorringe KL, Campbell IG.
Clin Cancer Res. 2008 Nov 15;14(22):7246-50.
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.
Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, Möller P, Stilgenbauer S, Pollack JR, Wirth T.
Blood. 2008 Nov 15;112(10):4202-12.
Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.
Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA, Lawler S.
Cancer Res. 2008 Nov 15;68(22):9125-30.
MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer.
Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ.
J Biol Chem. 2008 Nov 7;283(45):31079-86.
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.
Gal H, Pandi G, Kanner AA, Ram Z, Lithwick-Yanai G, Amariglio N, Rechavi G, Givol D.
Biochem Biophys Res Commun. 2008 Nov 7;376(1):86-90.
[Expression of microRNA-21 in invasive ductal carcinoma of the breast and its association with phosphatase and tensin homolog deleted
from chromosome expression and clinicopathologic features]
Huang GL, Zhang XH, Guo GL, Huang KT, Yang KY, Hu XQ.
Zhonghua Yi Xue Za Zhi. 2008 Nov 4;88(40):2833-7.
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma.
Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, Croce CM, Guttridge DC.
Cancer Cell. 2008 Nov 4;14(5):369-81.
miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells.
Würdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J, Weissleder R, Breakefield XO, Krichevsky AM.
Cancer Cell. 2008 Nov 4;14(5):382-93.
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal
acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.
Marcucci G, Maharry K, Radmacher MD, Mrózek K, Vukosavljevic T, Paschka P, Whitman SP, Langer C, Baldus CD, Liu CG, Ruppert AS,
Powell BL, Carroll AJ, Caligiuri MA, Kolitz JE, Larson RA, Bloomfield CD.
J Clin Oncol. 2008 Nov 1;26(31):5078-87.
Radiation modulation of microRNA in prostate cancer cell lines.
Josson S, Sung SY, Lao K, Chung LW, Johnstone PA.
Prostate. 2008 Nov 1;68(15):1599-606.
MicroRNA-221 and -222 pathway controls melanoma progression.
Felicetti F, Errico MC, Segnalini P, Mattia G, Carè A.
Expert Rev Anticancer Ther. 2008 Nov;8(11):1759-65.
Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia.
Mrózek K, Marcucci G, Paschka P, Bloomfield CD.
Curr Opin Oncol. 2008 Nov;20(6):711-8.
In-depth characterization of the microRNA transcriptome in a leukemia progression model.
Kuchenbauer F, Morin RD, Argiropoulos B, Petriv OI, Griffith M, Heuser M, Yung E, Piper J, Delaney A, Prabhu AL, Zhao Y, McDonald H,
Zeng T, Hirst M, Hansen CL, Marra MA, Humphries RK.
Genome Res. 2008 Nov;18(11):1787-97.
MicroRNAs and possible role in pituitary adenoma.
Zatelli MC, degli Uberti EC.
Semin Reprod Med. 2008 Nov;26(6):453-60.
The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma.
Luo X, Chegini N.
Semin Reprod Med. 2008 Nov;26(6):500-14.
MicroRNA: a new tool for biomedical risk assessment and target identification in human uterine leiomyomas.
Wei JJ, Soteropoulos P.
Semin Reprod Med. 2008 Nov;26(6):515-21.
Involvement of microRNAs in breast cancer.
Adams BD, Guttilla IK, White BA.
Semin Reprod Med. 2008 Nov;26(6):522-36.
A microRNA encoded in a highly conserved part of the mammalian HMGA2 gene.
von Ahsen I, Nimzyk R, Klemke M, Bullerdiek J.
Cancer Genet Cytogenet. 2008 Nov;187(1):43-4.
The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is
frequently lost in colon cancers.
Guo C, Sah JF, Beard L, Willson JK, Markowitz SD, Guda K.
Genes Chromosomes Cancer. 2008 Nov;47(11):939-46.
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities.
Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G,
Peschle C, De Maria R.
Nat Med. 2008 Nov;14(11):1271-7.
Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma.
Chang KW, Liu CJ, Chu TH, Cheng HW, Hung PS, Hu WY, Lin SC.
J Dent Res. 2008 Nov;87(11):1063-8.
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient
poor prognosis.
Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY.
RNA. 2008 Nov;14(11):2348-60.
MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1.
Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL, Jacob S, Majumder S.
J Biol Chem. 2008 Oct 31;283(44):29897-903.
MicroRNA-183 regulates Ezrin expression in lung cancer cells.
Wang G, Mao W, Zheng S.
FEBS Lett. 2008 Oct 29;582(25-26):3663-8.
Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23)
translocation.
Bousquet M, Quelen C, Rosati R, Mansat-De Mas V, La Starza R, Bastard C, Lippert E, Talmant P, Lafage-Pochitaloff M, Leroux D,
Gervais C, Viguié F, Lai JL, Terre C, Beverlo B, Sambani C, Hagemeijer A, Marynen P, Delsol G, Dastugue N, Mecucci C, Brousset P.
J Exp Med. 2008 Oct 27;205(11):2499-506.
miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines.
Lin CJ, Gong HY, Tseng HC, Wang WL, Wu JL.
Biochem Biophys Res Commun. 2008 Oct 24;375(3):315-20.
MicroRNA-10b and breast cancer metastasis.
Gee HE, Camps C, Buffa FM, Colella S, Sheldon H, Gleadle JM, Ragoussis J, Harris AL.
Nature. 2008 Oct 23;455(7216):E8-9
hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells.
Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z, You Y.
Brain Res. 2008 Oct 21;1236:185-93.
Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells.
Zhao HY, Ooyama A, Yamamoto M, Ikeda R, Haraguchi M, Tabata S, Furukawa T, Che XF, Iwashita K, Oka T, Fukushima M, Nakagawa
M, Ono M, Kuwano M, Akiyama S.
Cancer Lett. 2008 Oct 18;270(1):156-63.
Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling.
Petrocca F, Vecchione A, Croce CM.
Cancer Res. 2008 Oct 15;68(20):8191-4.
MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions.
Reddy SD, Ohshiro K, Rayala SK, Kumar R.
Cancer Res. 2008 Oct 15;68(20):8195-200.
MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory
networks in human breast cancer.
Findlay VJ, Turner DP, Moussa O, Watson DK.
Cancer Res. 2008 Oct 15;68(20):8499-506.
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death.
Schickel R, Boyerinas B, Park SM, Peter ME.
Oncogene. 2008 Oct 9;27(45):5959-74.
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.
Li Z, Lu J, Sun M, Mi S, Zhang H, Luo RT, Chen P, Wang Y, Yan M, Qian Z, Neilly MB, Jin J, Zhang Y, Bohlander SK, Zhang DE, Larson RA,
Le Beau MM, Thirman MJ, Golub TR, Rowley JD, Chen J.
Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15535-40.
MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells.
Papagiannakopoulos T, Shapiro A, Kosik KS.
Cancer Res. 2008 Oct 1;68(19):8164-72.
Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma.
Li W, Xie L, He X, Li J, Tu K, Wei L, Wu J, Guo Y, Ma X, Zhang P, Pan Z, Hu X, Zhao Y, Xie H, Jiang G, Chen T, Wang J, Zheng S, Cheng
J, Wan D, Yang S, Li Y, Gu J.
Int J Cancer. 2008 Oct 1;123(7):1616-22.
[Analysis of microRNA in drug-resistant breast cancer cell line MCF-7/ADR]
Cui XY, Guo YJ, Yao HR.
Nan Fang Yi Ke Da Xue Xue Bao. 2008 Oct;28(10):1813-5.
MicroRNA and oral cancer: future perspectives.
Gomes CC, Gomez RS.
Oral Oncol. 2008 Oct;44(10):910-4.
[The mechanism of apoptosis in human U87 glioma cells induced by miR-21 antisense oligonucleotide]
Shi L, Cheng Z, Zhang J, Li R, You Y, Fu Z.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Oct;25(5):497-501.
Control of cell proliferation pathways by microRNAs.
Bueno MJ, de Castro IP, Malumbres M.
Cell Cycle. 2008 Oct;7(20):3143-8.
Pharmacogenomics: a tool for improving cancer chemotherapy.
Monzó M, Navarro A, Ferrer G, Artells R.
Clin Transl Oncol. 2008 Oct;10(10):628-37.
Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes.
Schraders M, Jares P, Bea S, Schoenmakers EF, van Krieken JH, Campo E, Groenen PJ.
Br J Haematol. 2008 Oct;143(2):210-21.
Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.
Tsang WP, Kwok TT.
Apoptosis. 2008 Oct;13(10):1215-22.
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C,
Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY.
Cell Res. 2008 Oct;18(10):997-1006.
A truth serum for cancer--microRNAs have major potential as cancer biomarkers.
Chin LJ, Slack FJ.
Cell Res. 2008 Oct;18(10):983-4.
[Tumour genomics: an unstable landscape]
Moyret-Lalle C, Falette N, Grelier G, Puisieux A.
Bull Cancer. 2008 Oct;95(10):923-30.
Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma.
Pierson J, Hostager B, Fan R, Vibhakar R.
J Neurooncol. 2008 Oct;90(1):1-7.
In vivo imaging of functional targeting of miR-221 in papillary thyroid carcinoma.
Kim HJ, Kim YH, Lee DS, Chung JK, Kim S.
J Nucl Med. 2008 Oct;49(10):1686-93.
Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells.
Wang L, Pal S, Sif S.
Mol Cell Biol. 2008 Oct;28(20):6262-77.
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues.
Szafranska AE, Doleshal M, Edmunds HS, Gordon S, Luttges J, Munding JB, Barth RJ Jr, Gutmann EJ, Suriawinata AA, Marc Pipas J,
Tannapfel A, Korc M, Hahn SA, Labourier E, Tsongalis GJ.
Clin Chem. 2008 Oct;54(10):1716-24.
Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time
RT-PCR.
Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES.
Clin Chem. 2008 Oct;54(10):1696-704.
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, Negrini M.
Oncogene. 2008 Sep 25;27(43):5651-61.
Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres.
Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D, Xu L.
BMC Cancer. 2008 Sep 21;8:266.
Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?
Caligaris-Cappio F, Ghia P.
J Clin Oncol. 2008 Sep 20;26(27):4497-503.
Transcription factor and microRNA regulation in androgen-dependent and -independent prostate cancer cells.
Wang G, Wang Y, Feng W, Wang X, Yang JY, Zhao Y, Wang Y, Liu Y.
BMC Genomics. 2008 Sep 16;9 Suppl 2:S22.
Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using
artificial microRNA interference.
Wang Z, He YL, Cai SR, Zhan WH, Li ZR, Zhu BH, Chen CQ, Ma JP, Chen ZX, Li W, Zhang LJ.
Int J Cancer. 2008 Sep 15;123(6):1439-47.
miR-34a repression of SIRT1 regulates apoptosis.
Yamakuchi M, Ferlito M, Lowenstein CJ.
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13421-6.
A microRNA DNA methylation signature for human cancer metastasis.
Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez-Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ,
Gallagher WM, Eccles SA, Croce CM, Esteller M.
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13556-61.
MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines.
Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA, Nuovo G, Marsh CB, Nana-Sinkam SP.
Biochem Biophys Res Commun. 2008 Sep 5;373(4):607-12.
The MYCN oncogene is a direct target of miR-34a.
Wei JS, Song YK, Durinck S, Chen QR, Cheuk AT, Tsang P, Zhang Q, Thiele CJ, Slack A, Shohet J, Khan J.
Oncogene. 2008 Sep 4;27(39):5204-13.
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, Taccioli C, Zanesi N, Alder H, Hagan JP, Munker R, Volinia S, Boccadoro
M, Garzon R, Palumbo A, Aqeilan RI, Croce CM.
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12885-90.
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.
Foekens JA, Sieuwerts AM, Smid M, Look MP, de Weerd V, Boersma AW, Klijn JG, Wiemer EA, Martens JW.
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13021-6.
Mechanisms of microRNA deregulation in human cancer.
Deng S, Calin GA, Croce CM, Coukos G, Zhang L.
Cell Cycle. 2008 Sep 1;7(17):2643-6.
Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.
Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, Yang JM.
Biochem Pharmacol. 2008 Sep 1;76(5):582-8.
The microRNAs involved in human myeloid differentiation and myelogenous/myeloblastic leukemia.
Wang XS, Zhang JW.
J Cell Mol Med. 2008 Sep-Oct;12(5A):1445-55.
MicroRNA expression in lymphoid malignancies: new hope for diagnosis and therapy?
Lawrie CH.
J Cell Mol Med. 2008 Sep-Oct;12(5A):1432-44.
Hypoxia response and microRNAs: no longer two separate worlds.
Ivan M, Harris AL, Martelli F, Kulshreshtha R.
J Cell Mol Med. 2008 Sep-Oct;12(5A):1426-31.
MicroRNAs and prostate cancer.
Shi XB, Tepper CG, White RW.
J Cell Mol Med. 2008 Sep-Oct;12(5A):1456-65.
Micromanagers of malignancy: role of microRNAs in regulating metastasis.
Ma L, Weinberg RA.
Trends Genet. 2008 Sep;24(9):448-56.
Battling cancer on many fronts. Meeting on New Battlefields in Human Cancer--Attacking in Many Fronts.
Zanella F, Carnero A.
EMBO Rep. 2008 Sep;9(9):853-8.
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.
Roehle A, Hoefig KP, Repsilber D, Thorns C, Ziepert M, Wesche KO, Thiere M, Loeffler M, Klapper W, Pfreundschuh M, Matolcsy A,
Bernd HW, Reiniger L, Merz H, Feller AC.
Br J Haematol. 2008 Sep;142(5):732-44.
Epigenetic changes in gliomas.
Burgess R, Jenkins R, Zhang Z.
Cancer Biol Ther. 2008 Sep;7(9):1326-34.
Ovarian cancer biomarkers: current options and future promise.
Coticchia CM, Yang J, Moses MA.
J Natl Compr Canc Netw. 2008 Sep;6(8):795-802.
BIC is processed efficiently to microRNA-155 in Burkitt lymphoma cells.
Zhang T, Nie K, Tam W.
Leukemia. 2008 Sep;22(9):1795-7.
Benign metastasizing leiomyoma of the lung: clinicopathologic, immunohistochemical, and micro-RNA analyses.
Nuovo GJ, Schmittgen TD.
Diagn Mol Pathol. 2008 Sep;17(3):145-50.
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T.
Mod Pathol. 2008 Sep;21(9):1139-46.
The emergent role of microRNAs in molecular diagnostics of cancer.
Tam W.
J Mol Diagn. 2008 Sep;10(5):411-4.
Perspectives for improved and more accurate classification of thyroid epithelial tumors.
Eszlinger M, Krohn K, Hauptmann S, Dralle H, Giordano TJ, Paschke R.
J Clin Endocrinol Metab. 2008 Sep;93(9):3286-94.
Micro-RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer.
Svoboda M, Izakovicova Holla L, Sefr R, Vrtkova I, Kocakova I, Tichy B, Dvorak J.
Int J Oncol. 2008 Sep;33(3):541-7.
miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes.
Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, Xing R, Sun Z, Zheng X.
Nucleic Acids Res. 2008 Sep;36(16):5391-404.
Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the
malignant phenotype.
Connolly E, Melegari M, Landgraf P, Tchaikovskaya T, Tennant BC, Slagle BL, Rogler LE, Zavolan M, Tuschl T, Rogler CE.
Am J Pathol. 2008 Sep;173(3):856-64.
Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation
by a putative microRNA in the S1 colon cancer cell line.
To KK, Zhan Z, Litman T, Bates SE.
Mol Cell Biol. 2008 Sep;28(17):5147-61.
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators.
Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM.
Mol Cell Biol. 2008 Sep;28(17):5369-80.
MicroRNA and ovarian cancer.
Corney DC, Nikitin AY.
Histol Histopathol. 2008 Sep;23(9):1161-9.
[Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell
proliferation]
Cai SR, Chen CQ, Wang Z, He YL, Cui J, Wu WH, Wu H, Zhan WH.
Zhonghua Yi Xue Za Zhi. 2008 Aug 26;88(33):2326-30.
Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer.
Davoren PA, McNeill RE, Lowery AJ, Kerin MJ, Miller N.
BMC Mol Biol. 2008 Aug 21;9:76.
Protein tyrosine phosphatase receptor-type O (PTPRO) is co-regulated by E2F1 and miR-17-92.
Xu X, Hong Y, Kong C, Xu L, Tan J, Liang Q, Huang B, Lu J.
FEBS Lett. 2008 Aug 20;582(19):2850-6.
Functional integration of microRNAs into oncogenic and tumor suppressor pathways.
Lotterman CD, Kent OA, Mendell JT.
Cell Cycle. 2008 Aug 15;7(16):2493-9.
microRNAs and cancer: an overview.
Medina PP, Slack FJ.
Cell Cycle. 2008 Aug 15;7(16):2485-92.
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer.
Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Körner H, Knyazev P, Diebold J, Hermeking H.
Cell Cycle. 2008 Aug 15;7(16):2591-600.
Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive
activities in human hepatocellular carcinoma cells.
Huang S, He X, Ding J, Liang L, Zhao Y, Zhang Z, Yao X, Pan Z, Zhang P, Li J, Wan D, Gu J.
Int J Cancer. 2008 Aug 15;123(4):972-8.
A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation.
Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M, Wu K, Whittle J, Ju X, Hyslop T, McCue P, Pestell RG.
J Cell Biol. 2008 Aug 11;182(3):509-17.
Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells.
Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, Visintin I, Leiser A, Schwartz PE, Rutherford T, Mor G.
Oncogene. 2008 Aug 7;27(34):4712-23.
MicroRNA in acute myeloid leukemia.
Ritchie WJ, Flamant S, Rasko JE.
N Engl J Med. 2008 Aug 7;359(6):653.
Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer.
Prueitt RL, Yi M, Hudson RS, Wallace TA, Howe TM, Yfantis HG, Lee DH, Stephens RM, Liu CG, Calin GA, Croce CM, Ambs S.
Prostate. 2008 Aug 1;68(11):1152-64.
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer.
Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, Yfantis HG, Stephens RM, Croce
CM.
Cancer Res. 2008 Aug 1;68(15):6162-70.
Diagnostic and prognostic microRNAs in stage II colon cancer.
Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjøt L, Wiuf C, Sørensen FJ, Kruhøffer M, Laurberg S,
Kauppinen S, Ørntoft TF, Andersen CL.
Cancer Res. 2008 Aug 1;68(15):6416-24.
Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma.
Chen RW, Bemis LT, Amato CM, Myint H, Tran H, Birks DK, Eckhardt SG, Robinson WA.
Blood. 2008 Aug 1;112(3):822-9.
Cancer-associated genomic regions (CAGRs) and noncoding RNAs: bioinformatics and therapeutic implications.
Rossi S, Sevignani C, Nnadi SC, Siracusa LD, Calin GA.
Mamm Genome. 2008 Aug;19(7-8):526-40.
MicroRNA expression in canine mammary cancer.
Boggs RM, Wright ZM, Stickney MJ, Porter WW, Murphy KE.
Mamm Genome. 2008 Aug;19(7-8):561-9.
MiRNAs, epigenetics, and cancer.
Rouhi A, Mager DL, Humphries RK, Kuchenbauer F.
Mamm Genome. 2008 Aug;19(7-8):517-25.
Evidence for dietary regulation of microRNA expression in cancer cells.
Davis CD, Ross SA.
Nutr Rev. 2008 Aug;66(8):477-82.
Differential expression of microRNAs during hepatocarcinogenesis induced by methyl deficiency in rats.
Pogribny IP, Tryndyak VP, Ross SA, Beland FA.
Nutr Rev. 2008 Aug;66 Suppl 1:S33-5.
MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer.
Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA, Cohen MB.
Cancer Biol Ther. 2008 Aug;7(8):1288-96.
Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation.
París R, Henry RE, Stephens SJ, McBryde M, Espinosa JM.
Cell Cycle. 2008 Aug;7(15):2427-33.
Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas.
Shai RM, Reichardt JK, Chen TC.
Future Oncol. 2008 Aug;4(4):525-34.
Cooling skin cancer: menthol inhibits melanoma growth. Focus on "TRPM8 activation suppresses cellular viability in human melanoma".
Slominski A.
Am J Physiol Cell Physiol. 2008 Aug;295(2):C293-5.
Overlapping expression of microRNAs in human embryonic colon and colorectal cancer.
Monzo M, Navarro A, Bandres E, Artells R, Moreno I, Gel B, Ibeas R, Moreno J, Martinez F, Diaz T, Martinez A, Balagué O,
Garcia-Foncillas J.
Cell Res. 2008 Aug;18(8):823-33.
Predicting the future for people with lung cancer.
Xie Y, Minna JD.
Nat Med. 2008 Aug;14(8):812-3.
MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.
Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Wei Z, Kamath S, Chen DT, Dressman H, Lancaster JM.
Gynecol Oncol. 2008 Aug;110(2):206-15.
Circulating microRNAs as stable blood-based markers for cancer detection.
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin
DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M.
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8.
[Present status of and prospects for basic research on pancreatic cancer]
Zhao YP, Zhang TP.
Zhonghua Yi Xue Za Zhi. 2008 Jul 22;88(28):1945-7.
Reactive oxygen species and HIF-1 signalling in cancer.
Galanis A, Pappa A, Giannakakis A, Lanitis E, Dangaj D, Sandaltzopoulos R.
Cancer Lett. 2008 Jul 18;266(1):12-20.
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene.
Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, Li Y.
Oncogene. 2008 Jul 17;27(31):4373-9.
Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster.
Taguchi A, Yanagisawa K, Tanaka M, Cao K, Matsuyama Y, Goto H, Takahashi T.
Cancer Res. 2008 Jul 15;68(14):5540-5.
Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice.
Daikoku T, Hirota Y, Tranguch S, Joshi AR, DeMayo FJ, Lydon JP, Ellenson LH, Dey SK.
Cancer Res. 2008 Jul 15;68(14):5619-27.
Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer.
Nagel R, le Sage C, Diosdado B, van der Waal M, Vrielink JA, Bolijn A, Meijer GA, Agami R.
Cancer Res. 2008 Jul 15;68(14):5795-802.
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, Hong L, Liu J, Fan D.
Int J Cancer. 2008 Jul 15;123(2):372-9.
Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling.
Wong TS, Liu XB, Chung-Wai Ho A, Po-Wing Yuen A, Wai-Man Ng R, Ignace Wei W.
Int J Cancer. 2008 Jul 15;123(2):251-7.
Downregulation of BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal carcinoma cells.
Qin L, Zhang X, Zhang L, Feng Y, Weng GX, Li MZ, Kong QL, Qian CN, Zeng YX, Zeng MS, Liao DF, Song LB.
Biochem Biophys Res Commun. 2008 Jul 4;371(3):531-5.
Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.
Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM.
PLoS ONE. 2008 Jul 2;3(7):e2557.
The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence.
Poliseno L, Pitto L, Simili M, Mariani L, Riccardi L, Ciucci A, Rizzo M, Evangelista M, Mercatanti A, Pandolfi PP, Rainaldi G.
PLoS ONE. 2008 Jul 2;3(7):e2542.
miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.
Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H.
Cancer Res. 2008 Jul 1;68(13):5004-8.
Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis.
Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, Ghoshal K, Jacob ST.
Cancer Res. 2008 Jul 1;68(13):5049-58.
The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis.
Korpal M, Kang Y.
RNA Biol. 2008 Jul-Sep;5(3):115-9.
Inflammation: gearing the journey to cancer.
Kundu JK, Surh YJ.
Mutat Res. 2008 Jul-Aug;659(1-2):15-30.
[Effect of microRNA143 expression on cell proliferation in colonic carcinoma]
Liu H, Zhang SZ, Cai SR, Peng JP, Zheng S.
Zhonghua Zhong Liu Za Zhi. 2008 Jul;30(7):498-501.
Survivin knockdown combined with apoptin overexpression inhibits cell growth significantly.
Liu Q, Fu H, Xing R, Tie Y, Zhu J, Sun Z, Zheng X.
Cancer Biol Ther. 2008 Jul;7(7):1053-60.
The art of killing: double stroke with apoptin and survivin as a novel approach in cancer therapy.
Panigrahi S, Klonisch T, Los M.
Cancer Biol Ther. 2008 Jul;7(7):1061-2.
Aberrant expression of microRNA in polycythemia vera.
Bruchova H, Merkerova M, Prchal JT.
Haematologica. 2008 Jul;93(7):1009-16.
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.
Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, Pogribny IP.
Mol Cancer Ther. 2008 Jul;7(7):2152-9.
MicroRNA expression in lymphocyte development and malignancy.
Lawrie CH, Saunders NJ, Soneji S, Palazzo S, Dunlop HM, Cooper CD, Brown PJ, Troussard X, Mossafa H, Enver T, Pezzella F,
Boultwood J, Wainscoat JS, Hatton CS.
Leukemia. 2008 Jul;22(7):1440-6.
Small is beautiful: microRNAs and breast cancer-where are we now?
Verghese ET, Hanby AM, Speirs V, Hughes TA.
J Pathol. 2008 Jul;215(3):214-21.
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, Wong N.
Gastroenterology. 2008 Jul;135(1):257-69.
Exosomal microRNAs step into the biomarker arena.
Shih KK, Levine DA.
Gynecol Oncol. 2008 Jul;110(1):1-2.
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.
Taylor DD, Gercel-Taylor C.
Gynecol Oncol. 2008 Jul;110(1):13-21.
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin
lymphomas.
Nie K, Gomez M, Landgraf P, Garcia JF, Liu Y, Tan LH, Chadburn A, Tuschl T, Knowles DM, Tam W.
Am J Pathol. 2008 Jul;173(1):242-52.
MicroRNAs in normal and malignant hematopoiesis.
Garzon R, Croce CM.
Curr Opin Hematol. 2008 Jul;15(4):352-8.